2018/02/21

Leading specialists discuss new SMA laser technology at IMCAS 20th World Congress 2018 Paris France

Leading specialists discuss new SMA laser technology at IMCAS 20th World Congress 2018 Paris France

“A new microablative method of acoustic-interference microinjury of the tissues as a unique concept of laser technology”

The annual IMCAS World Congress was recently held from 1st to 3rd February 2018 at the Palais des Congrès, Paris. This year was particularly special as IMCAS celebrated its 20th anniversary, with an estimated 8,000 delegates welcomed to the event. IMCAS is committed to achieving the highest standards in Plastic Surgery and Dermatology and has now become one of the most important international courses dedicated to excellence in the teaching of subjects on ageing skin treatments.

RecoSMA® is a unique technology, developed and patented by LINLINE Medical Systems, and is an acousto-interference method for skin rejuvenation using an Er:YAG laser combined with the SMA (Spatially Modulated Ablation) Module that targets both the dermis and underlying tissues.

Speaking at the congress Dr Natalia Volkova, MD, PhD, Dermatovenerologist, who gave her presentation “A new microablative method of acoustic-interference microinjury of the tissues as a unique concept of laser technology”. This study concentrated on the long term results after using RecoSMA for skin rejuvenation, the treatment of scars, stretch marks and also surgical applications including the treatment of trophic ulcers. The study also discussed the actual mechanism of the RecoSMA technology and the science behind the SMA module itself in conjunction with Er:YAG laser (2940nm).

Very promising results have been achieved. (To evaluate the clinical and histological results, photographs were taken and ultrasound examinations carried out). To read more follow this link

 

 
to news list